Compare CAPL & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAPL | IART |
|---|---|---|
| Founded | 1992 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 850.5M | 1.1B |
| IPO Year | 2012 | 1996 |
| Metric | CAPL | IART |
|---|---|---|
| Price | $22.65 | $15.21 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.33 |
| AVG Volume (30 Days) | 47.0K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 9.96% | N/A |
| EPS Growth | ★ 96.15 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $1,869,806,000.00 | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | $2.80 | $3.40 |
| P/E Ratio | $86.69 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.61 | $8.70 |
| 52 Week High | $23.34 | $16.42 |
| Indicator | CAPL | IART |
|---|---|---|
| Relative Strength Index (RSI) | 58.73 | 72.94 |
| Support Level | $20.17 | $12.64 |
| Resistance Level | $22.99 | $16.35 |
| Average True Range (ATR) | 0.65 | 0.90 |
| MACD | 0.14 | 0.15 |
| Stochastic Oscillator | 73.94 | 99.10 |
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.